Annual Shareholders Equity
$2.23 M
-$9.87 M-81.56%
December 31, 2023
Summary
- As of February 26, 2025, ERNA annual stockholders equity is $2.23 million, with the most recent change of -$9.87 million (-81.56%) on December 31, 2023.
- During the last 3 years, ERNA annual shareholders equity has fallen by -$5.43 million (-70.84%).
- ERNA annual shareholders equity is now -91.24% below its all-time high of $25.50 million, reached on December 31, 2021.
Performance
ERNA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$45.39 M
-$36.87 M-432.41%
September 30, 2024
Summary
- As of February 26, 2025, ERNA quarterly stockholders equity is -$45.39 million, with the most recent change of -$36.87 million (-432.41%) on September 30, 2024.
- Over the past year, ERNA quarterly shareholders equity has dropped by -$47.63 million (-2132.83%).
- ERNA quarterly shareholders equity is now -229.02% below its all-time high of $35.18 million, reached on June 1, 2021.
Performance
ERNA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ERNA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -81.6% | -2132.8% |
| 3 y3 years | -70.8% | -715.1% |
| 5 y5 years | -70.8% | -715.1% |
ERNA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.2% | at low | -278.0% | at low |
| 5 y | 5-year | -91.2% | at low | -229.0% | at low |
| alltime | all time | -91.2% | at low | -229.0% | at low |
Eterna Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$45.39 M(+432.4%) |
| Jun 2024 | - | -$8.53 M(+149.9%) |
| Mar 2024 | - | -$3.41 M(-252.8%) |
| Dec 2023 | $2.23 M(-81.6%) | $2.23 M(-37.3%) |
| Sep 2023 | - | $3.56 M(-7.9%) |
| Jun 2023 | - | $3.87 M(-47.6%) |
| Mar 2023 | - | $7.38 M(-39.0%) |
| Dec 2022 | $12.11 M | $12.11 M(+37.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $8.81 M(-40.4%) |
| Jun 2022 | - | $14.78 M(-14.6%) |
| Mar 2022 | - | $17.31 M(-32.1%) |
| Dec 2021 | $25.50 M(+233.0%) | - |
| Dec 2021 | - | $25.50 M(+95.6%) |
| Sep 2021 | - | $13.04 M(-62.9%) |
| Jun 2021 | - | $35.18 M(-895.8%) |
| Mar 2021 | - | -$4.42 M(-157.7%) |
| Dec 2020 | $7.66 M | $7.66 M |
FAQ
- What is Eterna Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Eterna Therapeutics?
- What is Eterna Therapeutics annual shareholders equity year-on-year change?
- What is Eterna Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly shareholders equity year-on-year change?
What is Eterna Therapeutics annual stockholders equity?
The current annual shareholders equity of ERNA is $2.23 M
What is the all time high annual shareholders equity for Eterna Therapeutics?
Eterna Therapeutics all-time high annual stockholders equity is $25.50 M
What is Eterna Therapeutics annual shareholders equity year-on-year change?
Over the past year, ERNA annual stockholders equity has changed by -$9.87 M (-81.56%)
What is Eterna Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ERNA is -$45.39 M
What is the all time high quarterly shareholders equity for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly stockholders equity is $35.18 M
What is Eterna Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ERNA quarterly stockholders equity has changed by -$47.63 M (-2132.83%)